Physicians
Dr. Jon Pryor
Dr. Leo Fung
Dr. Joe Lee
Dr. Manoj Monga
Dr. Bruce Redmon
Dr. Joel Slaton
Staff
Keith Mason
Beth Kandaswamy
Jes Siiteri
Michelle Tsang

 

Biography Curriculum Vitae
Dr. Jon Pryor


Back to Contents

Previous Page ----| 1 | 2 | 3 | 4 |---- Next Page

________________________________________________________________

Contents of Page 1

Addresses/Appointments
PostGraduate Training
Funding
Publications- Books & Chapters

__________________________________________________________________________

CURRICULUM VITAE
(UPDATED 07/01)

JON LEE PRYOR, M.D.


HOSPITAL ADDRESS:

University of Minnesota

Telephone: 612-625-0662
Department of Urologic Surgery Fax: 612-624-4430

MCC 394 Delaware St. S.E.
Minneapolis, Minnesota 55455

APPOINTMENTS:

1991 Assistant Professor, Departments of Urologic
Surgery, University of Minnesota (primary appointment)

1991 Assistant Professor, Department of Cell Biology and Neuroanatomy, University of Minnesota, (joint appointment)

1992 Graduate Faculty, Department of Obstetrics and
Gynecology, University of Minnesota Hospital and
Clinics

1993 -1995 Clinic Director, Department of Urologic Surgery

1993 Assistant Professor, Department of Obstetrics and Gynecology (joint appointment) and Co-Director of University Reproductive Health Laboratory

1996 Associate Professor with Tenure, Department of Urologic Surgery, University of Minnesota
(primary appointment)

1996 Associate Professor, Departments of Cell Biology and Neuroanatomy; and Obstetrics and Gynecology, University
of Minnesota, (joint appointments)
1997-1998 Director, Center for Men=s Health and Infertility
Reproductive Health Associates, St. Paul, Minnesota

1997 Co-Editor - In-Chief, Journal of Andrology

2000 Interim Chair and Residency Program Director,
Department of Urologic Surgery

2001 Chair, Department of Urologic Surgery

2001 Professor, Departments of Urologic Surgery and Obstetrics and Gynecology, University of Minnesota (joint appointment)

2002 President, American Society of Andrology

EDUCATION:

1975-1979 B.A., Carleton College

1979-1983 M.D., University of Minnesota Medical School

1989 M.S., University of Virginia Graduate School
of Arts and Sciences

Back to Top

POSTGRADUATE TRAINING:

Internship - Surgery:

1983-1984 Hennepin County Medical Center; Minneapolis,
Minnesota

Residency - Surgery:

1984-1985 Hennepin County Medical Center; Minneapolis,
Minnesota

Residency - Urology:

1985-1989 University of Virginia; Charlottesville, Virginia

Research Fellow:

1989-1991 American Foundation of Urologic Disease
Scholar/Burroughs Wellcome Fellow, Departments
of Cell Biology/Neuroanatomy and Urologic Surgery,
University of Minnesota; Minneapolis, Minnesota

LICENSURE and BOARDS:
State of Minnesota License
Diplomate of the American Board of Urology, 1994

Back to Top


FUNDING:


1991-1992 University of Minnesota Graduate School
Grant-In Aid of Research $13,500
(J. Pryor, P.I.)

1992-1993 Minnesota Medical Foundation
Equipment Grant $10,500
(J. Pryor, P.I.)

1992-1997 National Institute of Child Health and
Human Development, Clinical
Investigator Award
Grant #1K08HD0097 $325,000
(J. Pryor, P.I.)

1994-1995 Minnesota Medical Foundation
Grant #SMF-978-95 $8,890
(J. Pryor, P.I.)

1995-1996 Promega Grant
Genetics Study, $4,000
(J. Pryor, P.I.)

1996-1997 Summit Medical Systems, Inc.
Development of an Infertility Database, $1,800
(J. Pryor, P.I.)

1998 Merck
Effect of Finasteride 1 mg
on Serum PSA in Men with Androgenetic Alopecia, $181,000
(J. Pryor, Co - P.I.)

1998 VIVUS, Inc
Evaluation of the Safety and Efficacy of Transurethral Alprostadil and Prozon HCl used in Combination for the Treatment of Erectile Dysfunction, $38,300
(J. Pryor, P.I.)

1998 VIVUS, Inc
Long-term Evaluation of the Safety and Efficacy of Transurethral Alprostadil and Prozon HCl used in Combinationforhe Treatment of Erectile
Dysfunction, $39,800
(J. Pryor, P.I.)

1998 N.I.H.
US Study of Semen Quality in Partners of Pregnant Women, $356,846 (J. Pryor, Co -investigator. Dr. Redmon did most of the work, though Dr. Pryor participated, especially in the initial design and setting up the study.)

1999 Schering Plough
An Open-Label Trial of Vasomax (Oral Phentolamine) in Spinal Cord Injured Patients with Mild to Moderate Erectile Dysfunction, $17,405 (J. Pryor, P.I.)

1999 TAP Pharmaceuticals
A Phase III at Home Use Study Evaluating the Efficacy and Safety of Escalating Roses of Uprima 2, 3, and 4 mg in the Treatment of Patients with Erectile Dysfunction, $31,799
(J. Pryor, P.I.)

2000 SDF Consultants
Effect of a Dietary Food Supplement Containing Carnitine on Sperm Motility, $126,366
(J. Pryor, P.I.)
2000 TAP Pharmaceuticals
A Phase III Crossover Study Evaluating the Efficacy and Safety of Uprima (Apomorphine HC1 Tablets) Sublingual (2,3,4,mg) in Combination with Sildenafil Citrate (25 or 50mg) in the Treatment of Male Erectile Dysfunction, $29,821 (J. Pryor, P.I.)

2000 PARKE-DAVIS
A double-blind, placebo-controlled, parallel group study to assess the effect of Pregabalin on reproductive function in healthy male subjects, $201,600 (J. Pryor, P.I.)

2000 MACROCHEM Corporation
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of Topiglan (Topical Gel Formation of Alprostadil and Sepa) For the Treatment of Male Erectile Dysfunction in an At-Home Setting, $32,433 (J. Pryor, P.I.)

2001 MACROCHEM Corporation
An Open-Label Continuation Trial of 1% Topiglan (Topical Gel Formulation 1%
Alprostadil and 5% SEPA) in Male ED Patients, $32,770 (J. Pryor, P.I.)

2001 TAP Pharmaceuticals
A Phase III, Double-Blind, Randomized, Parallel Study Evaluating the Safety and Efficacy of Uprima (apomorphine HCl tablets) Sublingual (2 and 3 mg) in the Treatment of Male Erectile Dysfunction, $37,501 (J. Pryor, P.I.)

2002 TAP Pharmaceuticals
A Phase III, Twelve-Month, Open-Label Flexible Dose, Safety Extension Study of
UprimaÒ Tablets (2 and 3 mg) in the Treatment of Male Erectile Dysfunction,
$51,948 (J. Pryor, P.I.)

2002 SCHERING PLOUGH
A Single-Blind, Multi-Center, Placebo-Controlled, Parallel Study to Assess the
Safety and Efficacy of Intralesional Alpha 2b Injections in the Treatment of
Peyronie's Disease, $27,000 (J. Pryor, P.I.)

Back to Top


PUBLICATIONS:

Books:

1. Robaire, B., Pryor, J.L., and Trasler, J.M. (co-editors): Handbook of Andrology.
Lawrence: Allen Press, 1995.

2. Pryor, J.L., Glass, S.L.: It's in the Male. Everyone's Guide to Men's Health. Minneapolis, Appleday Press, 2000.

3. Associate Editor for the Fifth Edition of Glenn's Urologic Surgery, 1998.

Chapters:

1. Pryor, J.L., and Howards, S.S.: Varicocele. In: Tanagho, Lue and McClure (eds): Contemporary management of impotence and infertility. Baltimore, Williams and Wilkins Company, 1988.

2. Pryor, J.L., Becher, E.F., and Sidi, A.A.: Overview of balloon catheters for transurethral dilatation of the prostate. In: Seminars in Interventional Radiology. Thieme Medical Publishers, Inc., 1991.

3. Pryor, J.L.: Androgen supplementation causes B.P.H. Proceedings of the 2nd International Androgen Workshop. New York, John Wiley & Sons, 1996.

4. Roberts, K.B., and Pryor, J.L.: Anatomy and physiology of the male reproductive tract. In: Hellstrom, W.J.G. (editor). Male Infertility and Sexual Dysfunction. New York: Springer, 1997.

5. Schow, D.A. and Pryor, J.L.: Vasectomy. In: Graham. S.D. and Glenn, J.F. Glenn=s Urologic Surgery. Phil., Lippincott-Raven Publishers, (1998).

6. Pryor, J.L. and Roberts, K.P.: Genetics of Male Infertility: Essentials for the Clinician. In: Vaughan, E.D. Jr. and Perlmutter, A.P. (Editors), Atlas of Clinical Urology. Vol. I. Impotence and Infertility. Philadelphia. Current Medicine, 1999.

7. Ober, C., Verp, M.S., Roberts, K.P., and Pryor, J. L.: Genetics of Infertility and Pregnancy Loss In: King, R.A., Rotter, J.I., and Motulsky, A.G. (Eds). The Genetic Basis of Common Diseases. New York. Oxford University Press, 2000.

8. Redmon, J.B., and Pryor, J.L.: Male Menopause. In: Teichman J, ed 20 Common Genitourinary Problems in Primary Care. McGray-Hill (in press).

Back to Top

Previous Page ----| 1 | 2 | 3 | 4 |---- Next Page

Fairview-University Medical Center University of Minnesota Department of Urologic Surgery University of Minnesota Center for Urologic Clinical Trials Home Disclaimer